2006 archive
PLANTS
CAN HELP PREVENT CANCER
The
Indena approach to chemoprevention presented at the 48O
Annual Meeting of the Italian Cancer Society
MIRTOSELECT® NEW LOGO CAMPAIGN
Another mark of quality introduced by Indena
INDENA
AND NERVIANO MEDICAL SCIENCES AGREE TO SCALE UP NEW HIGH
POTENCY MOLECULES
Two leading Italian research centers join forces to
develop new chemicals
PLANTS
HELP FIGHT CARDIOVASCULAR DISORDERS
Indena approach to dietary antioxidant treatment con contribute to
optimise nutrition
INDENA CONFIRMS WORLD LEADERSHIP IN BOTANICAL DERIVATIVES
Flourishing
turnover and healthy profits highlighted in annual report
INDENA
SIGNS LONG-TERM AGREEMENT WITH ALLIANCE PRINCIPLE
INGREDIENTS AS ITS CANADIAN DISTIBUTOR
EAST MEETS WEST TO UNVEIL SECRETS FOR A BEAUTIFUL SKIN
Indena and Kanebo Cosmetics present their olive fruit extract
OPEXTAN™
COSMETICS:
INDENA TO FOCUS ON PRODUCING HIGH PURIFIED ACTIVE PRINCIPLE AND
DRY EXTRACTS.
Fluid Extract lines to move to Greentech
2005 archive
THE SAFE
CONSUMPTION OF SOY ISOFLAVONES AS HORMONE REPLACEMENT
THERAPY
Fresh Evidence presented at the Chicago Symposium
Colon cancer: new possibilities of treatment from Colchicine derivatives
Indena illustrates its findings at the Stony Brook Symposium
Bilberry extracts: no more half truths
A new validated HPLC method by the Italian company Indena
MADEGLUCYL™, the natural way to maintain
healthy blood sugar levels
Indena presents its new patented botanical derivative
BEAUTY FROM BOTANICAL ACTIVES
New cosmentic ingredients from the Italian company Indena
QUALITY IN NUTRITIONAL SUPPLEMENTS
Indena illustrates guidelines for biologically complex materials
Download 2004 archive
OLIVE FRUITS AS A SOURCE OF HEALTH
Indena innovative extract out of the Mediterranean tradition
Indena presents two studies on IDN 5390 at the 16th EORTC-NCI-AACR
PACLITAXEL RESISTANCE: AN ITALIAN WAY FORWARD
INDENA OPENS DEVELOPING PERSPECTIVES ON TAXANE DERIVATIVES RESEARCH
PRESIDENT OF THE INDENA SCIENTIFIC BOARD RECEIVES THE VARRO TYLER AWARD
Dr. Ezio Bombardelli awarded for research in botanicals during the
American Society of Pharmacognosy 2004 International Congress
THE ITALIAN COMPANY INDENA PRESENTS A NEW LINE ON CANCER RESEARCH
Four Indena studies presented during the 95th American Association of Cancer Research Congress
(AACR)
INDENA MAKES PHYTOTHERAPY EVEN SAFER FOR BOTH PATIENTS AND THE ENVIRONMENT
New WHO guidelines on the cultivation of medicinal plants
Download 2003 archive
RISK OF HEART DISEASE REDUCED IN SMOKERS BY GRAPE SEEDS
An Italian study on Indena's LeucoselectTM Phytosome® extract was published in the recent October edition of the journal Metabolism
ITALIAN RESEARCH CONFIRMS THAT A NEW BOTANICAL ANTITUMOR MOLECULE IS READY FOR TOXICOLOGICAL AND CLINICAL DEVELOPMENT
During the international symposium on "Novel Approaches for the Discovery of Anticancer Agents" in Freiburg, the Milan National Tumor Institute presents its studies on Indena's IDN5390 molecule
Download 2002 archive
INDENA INTRODUCES POLINACEA
A NEW HIGHLY EFFECTIVE INGREDIENT FROM ECHINACEA
A NEW MOLECULE OBTAINED FROM PLANTS CAN MAKE
CHEMOTHERAPY MORE TOLERABLE AND EFFECTIVE
Three Italian studies presented in Frankfurt by Indena
REDUCTION OF MENOPAUSAL SYMPTOMS WITHOUT USE OF OESTROGENS: THE EFFICIENCY OF A PARTICULAR SOY EXTRACT IS SCIENTIFICALLY DEMONSTRATED
Understanding the Implications of the EU Traditional Herbal Medicine Directive: Indena shows the way in London
Indena sets out the importance for Higher Quality of Botanical Raw Materials
INDENA U.S.A. FREE OF PATENT INFRINGEMENT SUIT
United States Appeals Court dismisses
International Nutrition Company's patent infringement suit against Indena U.S.A.
INDENA'S SABALSELECT® CHOSEN FOR NIH SPONSORED CLINICAL TRIALS
The high quality of Indena's herbal products supported by their employment in American clinical trials
Download 2001 archive
INDENA SPONSORS ITALIAN RESEARCHERS' PARTICIPATION IN THE 2nd ITALIAN-JAPANESE SYMPOSIUM OF ORGANIC CHEMISTRY
TOWARDS MORE TOLERABLE CHEMOTHERAPY, WITH A NEW TAXANE MOLECULE
INDENA INCREASES ITS INTERNATIONAL PRESENCE
The Italian Company offers a world-wide market experience and research capabilities in the field of the botanical pure products
FDA APPROVES PHASE I CLINICAL TRIALS FOR POTENTIAL NEW ANTI-CANCER COMPOUND LICENSED TO BAYER BY INDENA
INDENA INAUGURATES ITS JAPANESE BRANCH
The Italian company consolidates its presence in the fifth largest global market

Indenature
2000
Indenature
2001
Indenature
2002
Indenature
2003
Indenature
2004
Indenature
2005
Indenature
2006
Indenature
2007
Indenature
2008
Indenature
2009
Indenature
2010